Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients

Autor:	Ying Bin Wang, Liu Wei Song, Zhuo Li, Quan Yuan, Yan Yan, Jun Zhang, Jia-Horng Kao, Cheng Yuan Peng, Chenghao Huang, Pei-Jer Chen, Shengxiang Ge, Ping Guo Liu, Chun-Jen Liu, Ding-Shinn Chen, Ningshao Xia
Rok vydání:	2012
Předmět:	HBsAg Treatment response business.industry Disease progression Gastroenterology cccDNA Hepatitis B core antibody level Hepatitis B medicine.disease Hepatitis B Chronic HBeAg Chronic hepatitis Immunology medicine Humans business
Zdroj:	Gut. 62:182.2-184
ISSN:	1468-3288 0017-5749
DOI:	10.1136/gutjnl-2012-302656
Popis:	We read with interest the recent article by Dandri emphasising the use of novel quantitative biomarkers as tools for predicting treatment response and disease progression in chronic hepatitis B infection (CHB).1 The authors carried out a comprehensive review of the clinical implications of quantitative measurement of viral biomarkers both in blood and in liver, such as: serum HBsAg, serum HBeAg and intrahepatic cccDNA, based on current knowledge.1 In addition to these, …
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aa0236bf061be6243dc0f6901880614 https://doi.org/10.1136/gutjnl-2012-302656 Zobrazit plný text záznamu